Prevalence of and factors associated with long COVID among US adults: a nationwide survey

Abstract Background People with long COVID report prolonged, multisystem involvement and significant disability. This study aimed to determine long COVID prevalence and factors associated with it among US adults using nationally representative data. Methods This cross-sectional analysis utilized dat...

Full description

Saved in:
Bibliographic Details
Main Authors: Juanjuan Shi, Rui Lu, Yan Tian, Fengping Wu, Xiaozhen Geng, Song Zhai, Xiaoli Jia, Shuangsuo Dang, Wenjun Wang
Format: Article
Language:English
Published: BMC 2025-05-01
Series:BMC Public Health
Subjects:
Online Access:https://doi.org/10.1186/s12889-025-22987-8
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849326901773991936
author Juanjuan Shi
Rui Lu
Yan Tian
Fengping Wu
Xiaozhen Geng
Song Zhai
Xiaoli Jia
Shuangsuo Dang
Wenjun Wang
author_facet Juanjuan Shi
Rui Lu
Yan Tian
Fengping Wu
Xiaozhen Geng
Song Zhai
Xiaoli Jia
Shuangsuo Dang
Wenjun Wang
author_sort Juanjuan Shi
collection DOAJ
description Abstract Background People with long COVID report prolonged, multisystem involvement and significant disability. This study aimed to determine long COVID prevalence and factors associated with it among US adults using nationally representative data. Methods This cross-sectional analysis utilized data from 2022 Behavioral Risk Factor Surveillance System survey, a nationally representative telephone survey conducted among noninstitutionalized adults aged ≥ 18 years residing in the United States. Age-adjusted prevalence of long COVID was calculated using weighted survey analysis. Poisson regression was employed to assess adjusted prevalence ratios (aPRs) associated with long COVID across various demographic, socioeconomic and health-related characteristics. Results Among 390,233 participants, 120,178 reported COVID-19, with 25,582 experiencing long COVID. Age-adjusted prevalence of self-reported COVID-19 and long COVID were estimated at 34.1% (95% CI, 33.7–34.4%) and 7.2% (95% CI, 7.0–7.4%) as of 2022, respectively. Among adults reporting COVID-19, 20.9% (95% CI, 20.5–21.4%) had ever experienced long COVID. An inverted U-shaped association was observed between long COVID risk and age, with the highest prevalence (23.5%) in the 45–54 age group. Long COVID was more prevalent among women (aPR, 1.40 [95% CI, 1.34–1.47]), individuals without a spouse (aPR, 1.06 [95% CI, 1.00–1.13]), uninsured (aPR, 1.16 [95% CI, 1.06–1.27]), and those with a high school education (aPR, 1.17 [95% CI, 1.12–1.23]), cardiovascular disease (aPR, 1.17 [95% CI, 1.09–1.25]), depressive disorder (aPR, 1.41 [95% CI, 1.34–1.48]), chronic obstructive pulmonary disease (aPR, 1.33 [95% CI, 1.24–1.43]), asthma (aPR, 1.28 [95% CI, 1.21–1.35]), and kidney disease (aPR, 1.11 [95% CI, 1.01–1.21]). Long COVID was less prevalent among non-Hispanic Black (aPR, 0.87 [95% CI, 0.81–0.95]), students (aPR, 0.87 [95% CI, 0.76–0.99]) or retired individuals (aPR, 0.89 [95% CI, 0.82–0.98]), and those with household incomes ≥$100,000 (aPR, 0.85 [95% CI, 0.79–0.92]). Conclusions Long COVID affects 7.2% of US adults, with higher vulnerability among women, middle-aged individuals, White individuals, socioeconomically disadvantaged groups, and those with chronic conditions. These findings underscore the need for targeted public health strategies to address disparities in long COVID burden and support high-risk populations.
format Article
id doaj-art-0af5d2ef38b64789ad115239705e1bdd
institution Kabale University
issn 1471-2458
language English
publishDate 2025-05-01
publisher BMC
record_format Article
series BMC Public Health
spelling doaj-art-0af5d2ef38b64789ad115239705e1bdd2025-08-20T03:48:02ZengBMCBMC Public Health1471-24582025-05-0125111010.1186/s12889-025-22987-8Prevalence of and factors associated with long COVID among US adults: a nationwide surveyJuanjuan Shi0Rui Lu1Yan Tian2Fengping Wu3Xiaozhen Geng4Song Zhai5Xiaoli Jia6Shuangsuo Dang7Wenjun Wang8Department of Infectious Diseases, Second Affiliated Hospital of Xi’an Jiaotong UniversityDepartment of Infectious Diseases, Second Affiliated Hospital of Xi’an Jiaotong UniversityDepartment of Infectious Diseases, Second Affiliated Hospital of Xi’an Jiaotong UniversityDepartment of Infectious Diseases, Second Affiliated Hospital of Xi’an Jiaotong UniversityDepartment of Infectious Diseases, Second Affiliated Hospital of Xi’an Jiaotong UniversityDepartment of Infectious Diseases, Second Affiliated Hospital of Xi’an Jiaotong UniversityDepartment of Infectious Diseases, Second Affiliated Hospital of Xi’an Jiaotong UniversityDepartment of Infectious Diseases, Second Affiliated Hospital of Xi’an Jiaotong UniversityDepartment of Infectious Diseases, Second Affiliated Hospital of Xi’an Jiaotong UniversityAbstract Background People with long COVID report prolonged, multisystem involvement and significant disability. This study aimed to determine long COVID prevalence and factors associated with it among US adults using nationally representative data. Methods This cross-sectional analysis utilized data from 2022 Behavioral Risk Factor Surveillance System survey, a nationally representative telephone survey conducted among noninstitutionalized adults aged ≥ 18 years residing in the United States. Age-adjusted prevalence of long COVID was calculated using weighted survey analysis. Poisson regression was employed to assess adjusted prevalence ratios (aPRs) associated with long COVID across various demographic, socioeconomic and health-related characteristics. Results Among 390,233 participants, 120,178 reported COVID-19, with 25,582 experiencing long COVID. Age-adjusted prevalence of self-reported COVID-19 and long COVID were estimated at 34.1% (95% CI, 33.7–34.4%) and 7.2% (95% CI, 7.0–7.4%) as of 2022, respectively. Among adults reporting COVID-19, 20.9% (95% CI, 20.5–21.4%) had ever experienced long COVID. An inverted U-shaped association was observed between long COVID risk and age, with the highest prevalence (23.5%) in the 45–54 age group. Long COVID was more prevalent among women (aPR, 1.40 [95% CI, 1.34–1.47]), individuals without a spouse (aPR, 1.06 [95% CI, 1.00–1.13]), uninsured (aPR, 1.16 [95% CI, 1.06–1.27]), and those with a high school education (aPR, 1.17 [95% CI, 1.12–1.23]), cardiovascular disease (aPR, 1.17 [95% CI, 1.09–1.25]), depressive disorder (aPR, 1.41 [95% CI, 1.34–1.48]), chronic obstructive pulmonary disease (aPR, 1.33 [95% CI, 1.24–1.43]), asthma (aPR, 1.28 [95% CI, 1.21–1.35]), and kidney disease (aPR, 1.11 [95% CI, 1.01–1.21]). Long COVID was less prevalent among non-Hispanic Black (aPR, 0.87 [95% CI, 0.81–0.95]), students (aPR, 0.87 [95% CI, 0.76–0.99]) or retired individuals (aPR, 0.89 [95% CI, 0.82–0.98]), and those with household incomes ≥$100,000 (aPR, 0.85 [95% CI, 0.79–0.92]). Conclusions Long COVID affects 7.2% of US adults, with higher vulnerability among women, middle-aged individuals, White individuals, socioeconomically disadvantaged groups, and those with chronic conditions. These findings underscore the need for targeted public health strategies to address disparities in long COVID burden and support high-risk populations.https://doi.org/10.1186/s12889-025-22987-8COVID-19Long COVIDEpidemiologyBRFSS
spellingShingle Juanjuan Shi
Rui Lu
Yan Tian
Fengping Wu
Xiaozhen Geng
Song Zhai
Xiaoli Jia
Shuangsuo Dang
Wenjun Wang
Prevalence of and factors associated with long COVID among US adults: a nationwide survey
BMC Public Health
COVID-19
Long COVID
Epidemiology
BRFSS
title Prevalence of and factors associated with long COVID among US adults: a nationwide survey
title_full Prevalence of and factors associated with long COVID among US adults: a nationwide survey
title_fullStr Prevalence of and factors associated with long COVID among US adults: a nationwide survey
title_full_unstemmed Prevalence of and factors associated with long COVID among US adults: a nationwide survey
title_short Prevalence of and factors associated with long COVID among US adults: a nationwide survey
title_sort prevalence of and factors associated with long covid among us adults a nationwide survey
topic COVID-19
Long COVID
Epidemiology
BRFSS
url https://doi.org/10.1186/s12889-025-22987-8
work_keys_str_mv AT juanjuanshi prevalenceofandfactorsassociatedwithlongcovidamongusadultsanationwidesurvey
AT ruilu prevalenceofandfactorsassociatedwithlongcovidamongusadultsanationwidesurvey
AT yantian prevalenceofandfactorsassociatedwithlongcovidamongusadultsanationwidesurvey
AT fengpingwu prevalenceofandfactorsassociatedwithlongcovidamongusadultsanationwidesurvey
AT xiaozhengeng prevalenceofandfactorsassociatedwithlongcovidamongusadultsanationwidesurvey
AT songzhai prevalenceofandfactorsassociatedwithlongcovidamongusadultsanationwidesurvey
AT xiaolijia prevalenceofandfactorsassociatedwithlongcovidamongusadultsanationwidesurvey
AT shuangsuodang prevalenceofandfactorsassociatedwithlongcovidamongusadultsanationwidesurvey
AT wenjunwang prevalenceofandfactorsassociatedwithlongcovidamongusadultsanationwidesurvey